EDGAR Filing Documents for 0001683168-22-001839

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001683168-22-001839

Filing Date

2022-03-22

Accepted

2022-03-22 17:20:50

Documents

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	xenetic_i10k-123121.htm iXBRL	10-K	1433446
2	NOVATION OF AGREEMENT ON CO-DEVELOPMENT AND THE TERMS OF EXCLUSIVE LICENSE, DATE	xenetic_ex1003.htm	EX-10.3	34867
3	EXCLUSIVE LICENSE AGREEMENT, DATED DECEMBER 20, 2021, BETWEEN LIPOXEN TECHNOLOGI	xenetic_ex1004.htm	EX-10.4	39142
4	AMENDMENT NUMBER ONE TO THE MASTER SERVICES AGREEMENT, DATED OCTOBER 12, 2021, B	xenetic_ex1028.htm	EX-10.28	45652
5	SECOND WORK ORDER TO MASTER SERVICE AGREEMENT, DATED OCTOBER 12, 2021, BETWEEN T	xenetic_ex1029.htm	EX-10.29	21729
6	LIST OF SUBSIDIARIES	xenetic_ex2101.htm	EX-21.1	3168
7	CONSENT OF MARCUM LLP	xenetic_ex2301.htm	EX-23.1	2192
8	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER	xenetic_ex3101.htm	EX-31.1	10944
9	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER	xenetic_ex3102.htm	EX-31.2	10903
10	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER	xenetic_ex3201.htm	EX-32.1	4837
16	GRAPHIC	image_001.jpg	GRAPHIC	69703
17	GRAPHIC	image_002.jpg	GRAPHIC	69209
	Complete submission text file	0001683168-22-001839.txt		6350757

Data Files

Seq	Description	Document	Type	Size
11	XBRL SCHEMA FILE	xbio-20211231.xsd	EX-101.SCH	40839
12	XBRL CALCULATION FILE	xbio-20211231_cal.xml	EX-101.CAL	47717
13	XBRL DEFINITION FILE	xbio-20211231_def.xml	EX-101.DEF	270762
14	XBRL LABEL FILE	xbio-20211231_lab.xml	EX-101.LAB	347345
15	XBRL PRESENTATION FILE	xbio-20211231_pre.xml	EX-101.PRE	327898
73	EXTRACTED XBRL INSTANCE DOCUMENT	xenetic_i10k-123121_htm.xml	XML	772305

Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701

Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720

Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)